Key facts
- Notable investors include CAS Star, Addor Capital, Innoangel Fund, Goldport Capital, Suzhou Angel Fund of Funds — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Xiangsheng Technology (Pharmaceuticals)
- ·The full record, as it builds
Funding rounds
No funding rounds for Xiangsheng Technology (Pharmaceuticals) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Xiangsheng Technology (Pharmaceuticals)
Manufacturer of bio-based and high-performance materials intended for industries seeking high-performance, sustainable materials for applications in biotechnology, electronics, and advanced manufacturing. The company offers intelligent microfluidic manufacturing of advanced materials, supported by academic research platforms, thereby enabling clients to gain access to research-driven, scalable production technologies.
- Sector
- Healthcare
- HQ
- Nanjing, China
- Founded
- 2023
- Website
- bio-xiangsheng.com/
- Ownership
- Privately Held (backing)
Xiangsheng Technology (Pharmaceuticals) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xiangsheng Technology (Pharmaceuticals) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xiangsheng Technology (Pharmaceuticals) in its N-PORT filings yet. We sweep new filings monthly.